Congratulations to Biochemistry and Biophysics faculty Brian Kuhlman who was promoted from associate professor to full professor effective March 1, 2013.

Three scientists at the UNC-CH (Marcey Waters, Brian Strahl, Xian Chen) have received a $1 million grant from the W.M. Keck Foundation’s Medical Research Program to study a widespread but largely unexplored phenomenon that may be implicated in many diseases, including cancer.

Congratulations to Dr. Qi Zhang, Assistant Professor of Biochemistry and Biophysics, who has received the 2013 Basil O’Connor Starter Scholar Research Award from the March of Dimes Foundation.

The protein Ras plays an important role in cellular growth control. Researchers have focused on the protein because mutations in its gene are found in more than 30 percent of all cancers, making it the most prevalent human oncogene.

PCLS utilizing a group of amino acids to engage with a chemical marker that signals gene activation

Research from the Wang and Strahl labs has shed new light on how epigenetic signals may function together to determine the ultimate fate of a stem cell.

Congratulations to Dr. Charles Carter, Jr., Professor of Biochemistry & Biophysics, who was elected as a 2012 AAAS fellow.

Congratulations to Nikolay Dokholyan, Professor of Biochemistry and Biophysics, for his election as a 2012 APS Fellow.

Scott Rothbart, PhD (left) and Brian Strahl, PhD (right)

Sept. 30, 2012 - New research from the Strahl lab has established the first link between the two most fundamental epigenetic tags -- histone modification and DNA methylation -- in humans.

Protein S unplugged–a new wrinkle on the old theme (ATVB; Oct 2012, pg 2387-2393)

A schematic from Dr. Majumder's paper "Inhibition of Intrinsic Xase by Protein S - A Novel, Regulatory role of Protein S Independent of Activated Protein C" in the October 2012 issue of Arteriosclerosis, Thrombosis, and Vascular Biology has been chosen as the cover image.

Sept 13, 2013 - Discovery by UNC researchers in the Parise lab uncover a prime suspect for new cancer drug development. The team’s findings were published in the journal Oncogene.

Life is full of choices, and even cells come to a fork in the road. They have to decide what to do about damage to their DNA: repair the damage, force the damaged cell to die, or allow the damage to transform the cell to a tumor cell. Read more on the work from the Xian Chen lab in the Department of Biochemistry & Biophysics that was published in Cell Death & Disease.

Dr. Stephen T. Crews, Professor of Biochemistry & Biophysics, accepted an invitation to serve as a member of the Neurogenesis and Cell Fate Study Section, Center for Scientific Review for the term beginning immediately and ending June 30, 2018. Members are selected on the basis of their demonstrated competence and achievement in their scientific discipline as evidenced by the quality of research accomplishments, publications in scientific journals, and other significant scientific activities, achievements and honors.

Tag: Faculty & Lab News

Kuhlman Promoted to Full Professor

UNC scientists awarded $1 million to develop new tools to study the protein methylome

Zhang awarded March of Dimes Starter Scholar award

New mechanism for cancer progression discovered by UNC and Harvard researchers

Wang discovers information from outside the genome influences stem cell differentiation, cancer development

Charles Carter elected as 2012 AAAS Fellow

Nikolay Dokholyan elected as a 2012 American Physical Society Fellow

Scientists in the Strahl lab find missing link between players in the epigenetic code

Rinku Majumder has the cover article in the October 2012 issue of ATVB

Cell death mystery yields new suspect for cancer drug development

UNC team reports a novel DNA Damage-Dependent Tumor Suppressor

Crews selected to serve on NIH Study Section